Hemoglobin m
Reading File
Finding Sources
Finding Sources
Searching the Web
Hemoglobin M variants methemoglobinemia clinical features mechanism
Reading File
Reading File
Reading File
I now have comprehensive information to give a thorough answer. Here is a complete overview of Hemoglobin M (HbM):
Hemoglobin M (HbM)
Definition
Hemoglobin M is a group of rare, structurally abnormal hemoglobins caused by point mutations in the globin genes (alpha, beta, or gamma chains) that stabilize heme iron in the ferric (Fe³⁺) state. This results in congenital, hereditary methemoglobinemia.
Molecular Mechanism
Normal hemoglobin requires heme iron in the ferrous (Fe²⁺) state to bind and carry oxygen. In HbM:
- A tyrosine is substituted for a histidine residue in the heme-binding pocket - typically at the proximal histidine (F8) or distal histidine (E7) position.
- Tyrosine forms a tight ionic complex with heme iron via its phenolate anion, which strongly stabilizes the ferric (Fe³⁺) form.
- Fe³⁺ cannot bind oxygen, rendering those subunits functionally useless for O₂ transport.
- The Fe³⁺ in HbM variants is exceptionally resistant to enzymatic reduction by methemoglobin reductase (cytochrome b₅ reductase), unlike normal methemoglobin which is quickly recycled. - Harper's Illustrated Biochemistry, 32nd Ed
Named Variants
All known carriers of HbM are heterozygotes (homozygous state is likely lethal). - Harper's Illustrated Biochemistry, 32nd Ed
| Variant | Chain Affected | Substitution |
|---|---|---|
| HbM Iwate (HbM) | α-chain | His87 (F8) → Tyr |
| HbM Boston | α-chain | His58 (E7) → Tyr |
| HbM Hyde Park | β-chain | His92 (F8) → Tyr |
| HbM Saskatoon | β-chain | His63 (E7) → Tyr |
| HbM Milwaukee-1 | β-chain | Val67 → Glu (exception - no His→Tyr) |
Other named variants include Fort Ripley, Kankakee, and Osaka.
R-T State Effects
- Alpha-chain variants (HbM Boston, HbM Iwate): The R-T equilibrium is shifted toward the T state (deoxy, low affinity). Oxygen affinity is reduced and the Bohr effect is absent.
- Beta-chain variants (HbM Hyde Park, HbM Saskatoon): R-T switching still occurs, so the Bohr effect is preserved.
- Harper's Illustrated Biochemistry, 32nd Ed
Genetics
- Inheritance: Autosomal dominant
- Caused by mutations in HBA1, HBA2 (alpha), HBB (beta), or HBG1, HBG2 (gamma) genes
- Even one mutant allele causes clinical disease (heterozygotes are affected)
- Gamma-chain variants (affecting HbF) produce cyanosis in newborns that resolves as fetal hemoglobin is replaced
Clinical Features
HbM patients typically have methemoglobin levels of 15-30% and are generally asymptomatic despite cyanosis. - StatPearls / NCBI
| Feature | Details |
|---|---|
| Cyanosis | The hallmark - persistent, slate-gray/bluish discoloration of skin and mucous membranes |
| Onset | Alpha-chain variants: cyanosis from birth. Beta-chain variants: appears at 6-9 months (when fetal Hb is replaced) |
| Oxygen therapy | Does NOT correct cyanosis (it is not due to cardiopulmonary disease) |
| Methylene blue | Does NOT work (unlike acquired methemoglobinemia) - because the Fe³⁺ is structurally locked in |
| Hemolytic anemia | Can occur in some variants (e.g., HbM Saskatoon, HbM Hyde Park) |
| Blue nails | Reported in HbM disease - Andrews' Diseases of the Skin |
Diagnosis
- Co-oximetry (multiwavelength spectrophotometry) - identifies methemoglobin fraction; pulse oximetry is unreliable and typically reads ~85% regardless of actual MetHb level
- Hemoglobin electrophoresis or HPLC - separates HbM from HbA; HbM has a brown color in blood
- DNA/gene sequencing - definitive identification of the specific variant
- Spectroscopic analysis - HbM has a characteristic absorption spectrum distinct from normal MetHb
Comparison: HbM vs. Cytochrome b₅ Reductase Deficiency
Both cause hereditary methemoglobinemia, but:
| Feature | HbM Disease | CYB5R Deficiency |
|---|---|---|
| Inheritance | Autosomal dominant | Autosomal recessive |
| Methylene blue response | None | Effective (Type I) |
| Neurologic involvement | Absent | Present in Type II (severe) |
| Treatment | None needed (usually) | Ascorbic acid, riboflavin |
Key Takeaways
- HbM stabilizes Fe³⁺ via a His→Tyr substitution near the heme pocket.
- Patients are cyanotic but otherwise well - a "benign cyanosis."
- Cyanosis does not respond to O₂ or methylene blue.
- All known carriers are heterozygotes; autosomal dominant transmission.
- Alpha-chain variants present at birth; beta-chain variants at 6-9 months.
- Harper's Illustrated Biochemistry, 32nd Ed; Basic Medical Biochemistry, 6th Ed; Murray & Nadel's Textbook of Respiratory Medicine; Rosen's Emergency Medicine
This is a shared conversation. Sign in to Orris to start your own chat.